DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f6206c/epidemiology_dysl) has announced the addition of the "Epidemiology: Dyslipidemia" report to their offering.
The large numbers of adults with dyslipidemia in the seven major markets countries can be directly attributed to lifestyle choices, such as high caloric intake and limited physical activity. There is a clear disparity between the number of total prevalent cases and diagnosed cases, as well as a failure to properly manage the disease in all patients.
Scope:
- Gain insight to market potential, including a robust 10-year epidemiology forecast of total prevalent cases of dyslipidemia.
- Understand the key epidemiologic risk factors associated with dyslipidemia.
Highlights:
Cardiovascular disease is a leading cause of morbidity and mortality in the world; there are an estimated 16.7 million deaths each year from cardiovascular disease worldwide.
Dyslipidemia is a major, modifiable risk factor for cardiovascular disease. Middle-aged, white men are more likely to be diagnosed and treated for dyslipidemia; however, the disease is most prevalent in post-menopausal women.
Less than half of the people who meet the diagnostic criteria for dyslipidemia are actually receiving treatment for the disorder, involving lifestyle modification, medication, or both. While this gap has narrowed considerably in recent years, a large proportion of statin-treated patients are still not meeting targeted lipid levels.
Key questions answered:
- What are the most robust epidemiological studies for dyslipidemia prevalence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure or risk factors affect the number of dyslipidemia cases in the forecast period?
Key Topics Covered:
- Executive Summary
- Disease definition and diagnosis criteria
- Disease definition for dyslipidemia
- Different diagnostic criteria for dyslipidemia
- Global variation and historical trends
- Dyslipidemia is underdiagnosed and undertreated
- Risk factors
- Gender
- Age
- Lifestyle factors
- Genetic predisposition
- Epidemiologic forecasting of dyslipidemia
- Sources of epidemiologic data
- Description of methods
- Epidemiologic results
- Current prevalent cases and future trends
- Annual growth rate of disease population
- Discussion
- Varying definitions of dyslipidemia make cross-country comparisons difficult
- Dyslipidemia is often undiagnosed
For more information visit http://www.researchandmarkets.com/research/f6206c/epidemiology_dysl
Source: Datamonitor